Transplant Diagnostics Market Size | Industry Analysis by 2027

Transplant Diagnostics Market to 2027- Global Analysis and Forecasts By Product & Services (Instruments, Reagents & Consumables, and Software & Services), Type (Solid Organ Transplantation, Soft Tissue Transplantation, and Stem Cell Transplantation), Technology (Molecular Assays and Non-Molecular Assays), Application (Diagnostic Applications and Research Applications), and End User (Hospitals & Transplant Centers, Research Laboratories & Academic Institutes, and Independent Reference Laboratories)

Publication Month: Apr 2019 | Report Code: TIPRE00003076 | No. of Pages: No. of Pages150 | Category: Biotechnology | Status: Published

The transplant diagnostics market size was estimated to reach US$ 1,542.89 million by 2027 from US$ 789.88 million in 2018; it is estimated to grow at a CAGR of 7.9% during 2019-2027.

Transplant diagnostics refers to the diagnostics tests conducted on the organs meant to be transplanted. These tests are either conducted pre-transplantation or post-transplantation. Some of the common techniques used in transplant diagnostics are sequence-based molecular assays, PCR-based molecular assays, and non-molecular assays in certain cases. Transplant diagnostics is an essential factor in organ transplantation as it avoids any further complications that could occur after a transplant procedure.

The transplant diagnostics market growth is attributed to the rising prevalence of cardiovascular diseases and significant growth of biotechnology industry. However, expensive organ transplant surgeries may hinder the growth of market.

Lucrative Regions for Transplant Diagnostics Market

Lucrative Regions for Transplant Diagnostics Market

Get more information on this report :



Market Insights

Rising Prevalence of Cardiovascular Diseases

CVDs are the leading cause of death across the globe. The aging population commonly shows the structural and functional alteration of vessels accumulation through their life. Thus, it increases the risk of developing cardiovascular diseases. As per the American College of Cardiology, it is stated that CVD contributes nearly 800,000 deaths in the US, which is approximately one in every three deaths. The coronary heart disease (CHD) contributes to the majority of CVD deaths which is further followed by stroke and heart failure. Nearly over 90 million Americans get diagnosed with CVD. In addition, it is stated that at a global level cardiovascular disease contributes around 31% of all deaths and is expected that the cost of the CVD will be approximately to US$ 1,044 billion by 2030.

The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. Owing to this, the need of transplant diagnostics for organ transplantation is likely to propel the market during the forecast period.

Product and Services-Based Insights

The global transplant diagnostics market, based on product and services, is segmented into instruments, reagents & consumables, and software & services. The reagents & consumables segment was the largest segment among the product and services subsegments in the transplant diagnostics market in 2018. However, the software & services segment is expected to witness growth in its demand at the fastest CAGR of 9.6% during 2019–2027.

Type-Based Insights

The global transplant diagnostics market, based on type, is segmented into solid organ transplantation, soft tissue transplantation, and stem cell transplantation. The solid organ transplantation segment held the largest share of the transplant diagnostics market in 2018 and is anticipated to continue to hold the largest market during the forecast period.

Technology-Based Insights

The global transplant diagnostics market, based on technology, is segmented into molecular assays and non-molecular assays. In 2018, the molecular assays systems segment held a larger share of the market and is expected to witness growth in its demand at a faster CAGR of 9.5% during 2019–2027.

Application-Based Insights

The global transplant diagnostics market, based on application, is segmented into diagnostic applications and research applications. In 2018, the diagnostic applications segment held a larger share of the market and is expected to grow at a faster rate during the coming years.

Strategic Insights

Report CoverageDetails
Market Size Value inUS$ 789.88 Million in 2018
Market Size Value byUS$ 1,542.89 Million by 2027
Growth rateCAGR of 7.9% from 2019-2027
Forecast Period2019-2027
Base Year2019
No. of Pages150
No. of Tables235
No. of Charts & Figures85
Historical data availableYes
Segments coveredProduct & Services , Type , Technology , Application , End User , and Geography
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the transplant diagnostics market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

Company Profiles

  • BIO-RAD LABORATORIES, INC
  • BIOMÉRIEUX SA
  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN N.V.
  • F. HOFFMANN-LA ROCHE LTD.
  • HOLOGIC INC.
  • LUMINEX CORPORATION
  • OMIXON INC.
  • ABBOTT

Frequently Asked Questions

Transplant diagnostics refers to the diagnostics tests that are conducted on the organs that are meant to be transplanted. These tests are performed pre and post transplantation.
Some of the common techniques used in transplant diagnostics include, sequence based molecular assays, and PCR based molecular assays and also non-molecular assays in certain cases.
The major key players are Abbott, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Omixon Inc., Hologic Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd, bioMérieux SA.
The List of Companies
  1. Thermo Fisher Scientific Inc.
  2. Abbott
  3. Illumina, Inc.
  4. F. Hoffmann-La Roche Ltd
  5. Bio-Rad Laboratories, Inc.
  6. bioMérieux SA
  7. QIAGEN
  8. Hologic Inc.
  9. Luminex Corporation
  10. Omixon Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the transplant diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global transplant diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00003076
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount